GuruFocus.com13d agobearish
Novo Nordisk Stock Plunges on Morgan Stanley Downgrade Warns of Semaglutide Patent CliffMorgan Stanley Cuts Novo Nordisk to Underweight as Semaglutide Risks Cloud Outlook
Notícias
Apenas manchetes de alto sinal - eventos macro, resultados, M&A, regulatório. Listicles e clickbait de analistas filtrados por padrão. Atualizado a cada hora.
135last 24h
869last 7d
144● bullish (7d)
99● bearish (7d)
214publishers
The Wall Street Journal28d agobearish
Novo Nordisk Shares Drop as Bank Downgrade Reflects Growth ConcernsThe stock has tumbled 70% since its June 2024 peak, as the drugmaker has contended with intensifying competition from rival Eli Lilly as well as knockoff versions of its blockbuster Ozempic diabetes and Wegovy weight-loss jabs.